Loading...
Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Daniel Donoghue

    TitleProfessor
    SchoolUniversity of California, San Diego
    DepartmentChemistry and Biochemistry
    Address9500 Gilman Drive #0367
    CA La Jolla 92093
    Phone858-534-7146
    vCardDownload vCard

      Collapse Research 
      Collapse Research Activities and Funding
      Abberant Activation of FGFR3 Signaling in Human Cancer
      NIH/NCI R01CA090900May 1, 2003 - Apr 30, 2009
      Role: Principal Investigator
      Regulation of Receptor Tyrosine Kinases
      NIH/NIGMS R01GM065490Jul 1, 2002 - Jun 30, 2006
      Role: Principal Investigator
      Transmembrane Domains of Receptor Tyrosine Kinases
      NIH/NIGMS R01GM061163Jul 1, 2001 - Jun 30, 2002
      Role: Principal Investigator
      Biochemistry of Growth Regulation and Oncogenesis
      NIH/NCI T32CA009523Jul 1, 1985 - Jun 30, 2019
      Role: Principal Investigator
      MOLECULAR STUDIES OF TRANSFORMING GROWTH FACTORS
      NIH/NIDCR R01DE012581Jul 1, 1985 - Jul 31, 2002
      Role: Principal Investigator
      MOLECULAR STUDIES OF TRANSFORMING GROWTH FACTORS
      NIH/NCI R01CA040573Jul 1, 1985 - Jun 30, 1997
      Role: Principal Investigator
      EXPRESSION OF RETROVIRAL ENVELOPE GENE FUSION PROTEINS
      NIH/NCI R01CA034456Apr 1, 1983 - Apr 30, 2001
      Role: Principal Investigator

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Jiang MY, Lee TL, Hao SS, Mahooti S, Baird SM, Donoghue D, Haas M. Visualization of early prostatic adenocarcinoma as a stem cell disease. Oncotarget. 2016 Nov 15; 7(46):76159-76168. PMID: 27764770.
        View in: PubMed
      2. Gallo LH, Nelson KN, Meyer AN, Donoghue D. Functions of Fibroblast Growth Factor Receptors in cancer defined by novel translocations and mutations. Cytokine Growth Factor Rev. 2015 Aug; 26(4):425-49. PMID: 26003532.
        View in: PubMed
      3. Gallo LH, Meyer AN, Motamedchaboki K, Nelson KN, Haas M, Donoghue D. Novel Lys63-linked ubiquitination of IKKß induces STAT3 signaling. Cell Cycle. 2014; 13(24):3964-76. PMID: 25486864; PMCID: PMC4615003.
      4. Meyer AN, Drafahl KA, McAndrew CW, Gilda JE, Gallo LH, Haas M, Brill LM, Donoghue D. Tyrosine phosphorylation allows integration of multiple signaling inputs by IKKß. PLoS One. 2013; 8(12):e84497. PMID: 24386391; PMCID: PMC3873999.
      5. Fiñones RR, Yeargin J, Lee M, Kaur AP, Cheng C, Sun P, Wu C, Nguyen C, Wang-Rodriguez J, Meyer AN, Baird SM, Donoghue D, Haas M. Early human prostate adenocarcinomas harbor androgen-independent cancer cells. PLoS One. 2013; 8(9):e74438. PMID: 24086346; PMCID: PMC3783414.
      6. Meyer AN, Gastwirt RF, Schlaepfer DD, Donoghue D. The cytoplasmic tyrosine kinase Pyk2 as a novel effector of fibroblast growth factor receptor 3 activation. J Biol Chem. 2004 Jul 02; 279(27):28450-7. PMID: 15105428.
        View in: PubMed
      7. Lenormand JL, Dellinger RW, Knudsen KE, Subramani S, Donoghue D. Speedy: a novel cell cycle regulator of the G2/M transition. EMBO J. 1999 Apr 01; 18(7):1869-77. PMID: 10202150; PMCID: PMC1171272.